Kirn; David

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kirn; David.The latest application filed is for "oncolytic vaccinia virus cancer therapy".

Company Profile

4.20.24

Kirn; David - Mill Valley CA
Kirn; David - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Oncolytic Vaccinia Virus Cancer Therapy App 20210322578 - Kirn; David	2021-10-21
Methods and compositions for production of vaccina virus Grant 10,767,166 - Kirn , et al. Sep	2020-09-08
Oncolytic Vaccinia Virus Cancer Therapy App 20200009269 - Kirn; David	2020-01-09
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus Grant 10,434,169 - Kirn , et al. O	2019-10-08
Methods And Compositions For Production Of Vaccina Virus App 20190169578 - KIRN; David ; et al.	2019-06-06
Methods and compositions for production of vaccinia virus Grant 10,202,581 - Kirn , et al. Feb	2019-02-12
Oncolytic Vaccinia Virus Cancer Therapy App 20180256751 - KIRN; David	2018-09-13
Generation Of Antibodies To Tumor Antigens And Generation Of Tumor Specific Complement Dependent Cytotoxicity By Administration Of Oncolytic Vaccinia Virus App 20180214538 - KIRN; David ; et al.	2018-08-02
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus Grant 9,919,047 - Kirn , et al. March 20, 2	2018-03-20
Oncolytic vaccinia virus cancer therapy Grant 9,919,062 - Kirn March 20, 2	2018-03-20
Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses Grant 9,827,278 - Kirn November 28, 2	2017-11-28
Methods And Compositions For Production Of Vaccina Virus App 20170298324 - KIRN; David ; et al.	2017-10-19
Methods and compositions for production of vaccinia virus Grant 9,719,105 - Kirn , et al. August 1, 2	2017-08-01
Oncolytic Vaccinia Virus Cancer Therapy App 20160129135 - Kirn; David	2016-05-12
Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers Using GM-CSF-Expressing Poxviruses App 20160038548 - KIRN; DAVID	2016-02-11
Oncolytic vaccinia virus cancer therapy Grant 9,226,977 - Kirn January 5, 2	2016-01-05
Oncolytic vaccinia virus combination cancer therapy Grant 9,180,151 - Kirn , et al. November 10, 2	2015-11-10
Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses Grant 9,180,149 - Kirn November 10, 2	2015-11-10
Oncolytic Vaccinia Virus Cancer Therapy App 20150202325 - Kirn; David	2015-07-23
Methods and compositions concerning poxviruses and cancer Grant 8,986,674 - Kirn , et al. March 24, 2	2015-03-24
Oncolytic vaccinia virus cancer therapy Grant 8,980,246 - Kirn March 17, 2	2015-03-17
Generation Of Antibodies To Tumor Antigens And Generation Of Tumor Specific Complement Dependent Cytotoxicity By Administration Of Oncolytic Vaccinia Virus App 20150037355 - Kirn; David ; et al.	2015-02-05
Oncolytic Vaccinia Virus Combination Cancer Therapy App 20140322173 - KIRN; DAVID ; et al.	2014-10-30
Methods And Compositions For Production Of Vaccina Virus App 20140162342 - Kirn; David ; et al.	2014-06-12
Oncolytic vaccinia virus combination cancer therapy Grant 8,747,837 - Kirn , et al. June 10, 2	2014-06-10
Methods and Compositions Concerning Poxviruses and Cancer App 20130183271 - KIRN; David ; et al.	2013-07-18
Methods and compositions concerning poxviruses and cancer Grant 8,329,164 - Kirn , et al. December 11, 2	2012-12-11
Oncolytic Vaccinia Virus Cancer Therapy App 20120276053 - Kirn; David	2012-11-01
Oncolytic Vaccinia Virus Combination Cancer Therapy App 20120230958 - Kirn; David ; et al.	2012-09-13
Oncolytic Vaccinia Virus Cancer Therapy App 20100303714 - Kirn; David	2010-12-02
Methods and Compositions Concerning Poxviruses and Cancer App 20090004723 - Kirn; David ; et al.	2009-01-01
Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses App 20080286237 - Kirn; David	2008-11-20
Systemic Treatment Of Metastatic And/or Systemically-disseminated Cancers Using Gm-csf-expressing Poxviruses App 20070065411 - Kirn; David	2007-03-22
Methods and compositions concerning poxviruses and cancer App 20060099224 - Kirn; David	2006-05-11
Single Agent Method For Killing Tumor And Tumor Associated Endothelial Cells Using Adenoviral Mutants App 20020037274 - WILLIAMS, ANGELICA ; et al.	2002-03-28
Adenovirus-chemotherapeutic Combination For Treating Cancer App 20010006633 - KIRN, DAVID	2001-07-05
Cytopathic adenoviral E1B mutated viruses for therapy and prophylaxis of neoplasia Grant 6,080,578 - Bischoff , et al. June 27, 2	2000-06-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.